Pages that link to "Q46098827"
Jump to navigation
Jump to search
The following pages link to Sunitinib, a novel therapy for anthracycline- and cisplatin-refractory malignant pheochromocytoma (Q46098827):
Displaying 20 items.
- Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas (Q33401986) (← links)
- Sunitinib for refractory malignant pheochromocytoma: two case reports (Q33413239) (← links)
- Mitochondrial Deficiencies in the Predisposition to Paraganglioma (Q33844924) (← links)
- Clinical experiences of pheochromocytoma in Korea. (Q34474643) (← links)
- Metastatic paraganglioma (Q34480015) (← links)
- Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma (Q36125143) (← links)
- Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas (Q36804496) (← links)
- Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas. (Q36932510) (← links)
- Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies (Q37990768) (← links)
- Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma (Q38106904) (← links)
- Targeted therapy with kinase inhibitors in aggressive endocrine tumors (Q38107011) (← links)
- Pheochromocytomas in Multiple Endocrine Neoplasia Type 2. (Q38614500) (← links)
- Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines (Q39328101) (← links)
- Tianeptine interferes with microtubule organization and hormone secretion of pheochromocytoma cells (Q42670989) (← links)
- Targeted therapies, prognostic and predictive factors in endocrine oncology (Q45797561) (← links)
- A Case of Malignant Metastatic Pheochromocytoma After Eight Years of Primary Diagnosis (Q45821935) (← links)
- Sunitinib in the therapy of malignant paragangliomas: report on the efficacy in a SDHB mutation carrier and review of the literature. (Q51397534) (← links)
- A new approach to the treatment of metastatic paraganglioma: sorafenib. (Q54337099) (← links)
- Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma. (Q54542037) (← links)
- Metastatic pheochromocytoma in MEN 2A: A rare association (Q88204415) (← links)